MK-677 vs Melanotan II
A comprehensive, data-driven comparison of MK-677 (Ibutamoren) and Melanotan II (MT-2). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | MK-677 Ibutamoren, Nutrobal | Melanotan II MT-2, Melanotan 2 |
|---|---|---|
| FDA Status | Phase 2 | Not submitted |
| Category | Growth Hormone | Sexual Health |
| Primary Use | Growth hormone optimization and muscle growth | Tanning and sexual dysfunction (research) |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $50 - $100/mo | $30 - $60/mo |
| Administration | Oral | Subcutaneous injection |
| Typical Dose | 10-25mg daily | 0.25-1mg 2-3x per week |
| Frequency | Daily | As needed |
| Mechanism | Oral growth hormone secretagogue that mimics ghrelin to stimulate GH and IGF-1 release | Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on sexual arousal |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Moderate | Low |
| Clinical Trial Phase | Phase 2 | N/A |
Key Differences
- 1Melanotan II is generally more affordable ($30 - $60/mo) compared to MK-677 ($50 - $100/mo).
- 2MK-677 is administered via oral, while Melanotan II uses subcutaneous injection.
- 3MK-677 is dosed daily, while Melanotan II is as needed.
- 4MK-677 has moderate-quality evidence, while Melanotan II has low-quality evidence.
- 5They belong to different categories: MK-677 (Growth Hormone) vs Melanotan II (Sexual Health).
Which Is Better For...
Melanotan II
More budget-friendly option with lower monthly costs
Melanotan II
More convenient dosing schedule (as needed)
MK-677
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| MK-677 | $50 - $100/mo | Phase 2 | Various research labs |
| Melanotan II | $30 - $60/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
MK-677 works via Oral growth hormone secretagogue that mimics ghrelin to stimulate GH and IGF-1. Melanotan II works via Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on. They differ in FDA approval status, efficacy data, and cost.
MK-677 typically costs $50 - $100/mo, while Melanotan II costs $30 - $60/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
MK-677 is not FDA-approved (Phase 2). Melanotan II is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of MK-677 include Increased appetite, Water retention, Fatigue. Common side effects of Melanotan II include Nausea, Flushing, Spontaneous erections. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
MK-677 (Ibutamoren) is an orally-active growth hormone secretagogue that mimics the action of ghrelin. Unlike peptide injections, it is taken orally and has a long half-life allowing once-daily dosing...
View Full MK-677 GuideMelanotan II is a synthetic analog of alpha-melanocyte stimulating hormone that binds to melanocortin receptors. Originally developed for skin tanning protection against UV damage, it was found to hav...
View Full Melanotan II GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between MK-677 and Melanotan II should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.